1Almadrones LA. Treatment advances in ovarian cancer. Cancer Nurs, 2003,26(6 Suppl):16s-20s
2Armstrong DK. Relapsed ovarian cancer: challenges and management strategies for a chronic disease. Oncologist, 2002,7(Suppl 5):20-28
3Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol,2000, 78(3 pt1): 302-308
4Hamilton AB. Psychological aspects of ovarian cancer. Cancer Invest, 1999,17(5): 335-341
5Foltz A, Sullivan J. Reading level, learning presentation preference, and desire for information among cancer patients. J Cancer Educ, 1996, 11(1):32-38
6Doyle C, Crump M, Pintilie M, et al. Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol, 2001, 19(5): 1266-1274
7Carter JR, Chen MD, Fowler JM, et al. The effect of prolonged cycles of chemotherapy on quality of life in gynecologic cancer patients. J Obstet Gynaecol Res, 1997, 23(2): 197-203
8Kornblith AB, Thaler HT, Wong G, et al. Quality of life of women with ovarian cancer. Gynecol Oncol,1995, 59(2):231-242
9Payne SA. A study of quality of life in cancer patients receiving palliative chemotherapy. Soc Sci Med ,1992, 35(12):1505-1509
10Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer, 2000,88(1):144-153
4Santin AD,Fenghuang Z,Bellone S,et al.Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium dentification of candidate molecular markers for ovarian cancer diagnosis and therapy[J].Cancer,2004,11 (2):14-25.
5Lee S,Choi EJ,Jin C,et al.Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line[J].Gynecol Oncol,2005,97(1):26-34.
6The SH,Hill AD,Lee AW,et al.Raised plasma endostatin levels correlate inversely with breast cancer angiogenesis[J].J Surg Res,2004,116(1):165-171.
7Kim YM,Hwang S,Kim YM,et al.Endostatin blocks vascular endothelial growth factor mediated signaling via direct interaction with KDR/F1K-1[J].J Biol Chem,2002,277(31):27872-27879.
8Hajitou A,Grignet C,Devy L,et al.The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells[J].FA S EB J,2002,16 (13):1802-1804.
9Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual [ M ]. 7th edition. New York: Springer, 2009:103 - 115.
